VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors
Thus, in the early 1990s, pentadecapeptide BPC 157 [1,3,4,9,32,33,34,92] appeared as a late offshoot of the cytoprotectionorganoprotection concept of Robert and Szabo [32,33,34,35,36,37,38,39,40,41,42], for epithelial and endothelial protection
Anyone with active cancer, autoimmune disease, severe kidney or liver dysfunction, or unstable cardiovascular disease should not use peptides without expert supervision
Symptoms of real deficiency include fatigue, tingling or numbness in hands and feet, memory and concentration issues, mouth ulcers and pale skin, and a GP blood test is the only reliable way to confirm it